top of page
lungs 4.png

Living with COPD?

Verona study explores a combination of two investigational medications—ensifentrine and glycopyrrolate—designed to improve breathing and reduce inflammation without the use of steroids.

Gradient Ocean
shutterstock_2224399743.jpg

Who Can Participate?

You may qualify if you:

  • Are between 40 to 80 years old

  • Have been diagnosed with COPD 

  • Are not currently taking medications for COPD, or are only using rescue medications, or taking LABA/ICS medications

​

Study Timeline

  • A 7- to 14-day screening period

  • A 28-day treatment period

  • A 7-day follow-up visit

About the Study

The purpose of this study is to evaluate how the body responds to the combination of ensifentrine and glycopyrrolate, both together and individually. The study medication is administered as an inhaled treatment and may help open the airways and reduce inflammation in the lungs.

Interested in Participating?

Schedule a Pre-Screen Appointment:

or

Complete the Form Below

bottom of page